Biomarkers of Parkinson's disease: current status and future perspectives. - Wikidata - thesis-toulmin - TriplyDB

Biomarkers of Parkinson's disease: current status and future perspectives.

Biomarkers of Parkinson's disease: current status and future perspectives.

http://www.wikidata.org/entity/Q38043841

about

The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease Unbiased approaches to biomarker discovery in neurodegenerative diseases Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study.Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.Mini Review: linkages between essential tremor and Parkinson's disease?Alpha-Synuclein as a Biomarker for Parkinson's Disease.Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.Instrumented functional reach test differentiates individuals at high risk for Parkinson's disease from controls Clinical utility of visualisation of nigrosome-1 in patients with Parkinson's disease.A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.

P2860

Q28660352-F2CC7668-9D55-44D5-A02C-8BFB7D75D7FB Q30529658-CEF234E2-721F-4EA1-8C4B-58D3849A6236 Q34625918-4FF67B99-6789-400C-8C74-85767F4F474D Q35027763-9C08BD97-AA4C-4773-821C-9CD1F4F00A3E Q36374541-1CCA0CB1-F94E-4543-9EE1-C5CF1547ED76 Q37057709-14F62337-F26E-4943-BF56-A17507AAE14C Q38759482-EC97A264-A861-4A8C-AB74-D5F5684128AB Q41911647-9C52CD2E-4D50-4B20-BB97-7732094C8B33 Q41992235-E0742895-B844-41B9-A994-670C7C038183 Q47653671-93AA0055-639C-4BF6-BED7-F9114BD0DE6D Q51620455-09973241-2D6E-4E8A-8355-31AA0A875D38 Q51761574-06C6E2E5-9215-4784-AFDB-198EEA083DCD

P2860

Biomarkers of Parkinson's disease: current status and future perspectives.

http://www.wikidata.org/entity/Q38043841

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Biomarkers of Parkinson's disease: current status and future perspectives.

@en

type

label

Biomarkers of Parkinson's disease: current status and future perspectives.

@en

prefLabel

Biomarkers of Parkinson's disease: current status and future perspectives.

@en

P1433

Q38043841-3A41F939-BA5B-4BB5-95AF-4C453219FD12

P1476

Q38043841-14AB0C89-DD41-4F24-ACF4-758969E72612

P2093

Q38043841-1947D1CD-67DC-41F3-AC59-7904C54588CC

Q38043841-22202CBB-5BD2-4844-83C0-57D36B91C273

Q38043841-55F84E9D-06CA-48E5-A229-7B424BA76C99

Q38043841-67CB28EE-4D9B-4B55-8EED-4F660C32AA98

Q38043841-7CE66018-4E26-4BD7-8EB5-B387A38BCC2D

P2860

Q38043841-015FA3F4-9F2C-4E4E-AF1B-6842D74412D6

Q38043841-03728FC7-1B24-4287-BB97-BD779B9E8F86

Q38043841-05E734E0-A332-4537-B5F0-AB04FA5AD10E

Q38043841-0828BF23-0FBD-4117-8699-C0B93C6B3014

Q38043841-133197A1-A33C-4721-8BA5-5E30B57131DE

Q38043841-183A0ECC-1515-4BD9-A110-1A838CA008FA

Q38043841-1B18CD8B-906B-4EC7-970E-86A7B55F1853

Q38043841-1E586E0F-6F40-4FAD-A814-34C3C6ADAFDC

Q38043841-23137F6A-876D-42FE-91CC-2EED1AC997FF

Q38043841-2E53C349-B10B-45D3-998F-C07563FDB8AA

P304

Q38043841-CD21EC22-3A47-4D08-B412-C6298CC9B3D9

P31

Q38043841-20220FD7-23E8-415F-AB0B-B9A6ED4EAADC

P356

Q38043841-FDF4CBC5-E899-4823-A5A3-66EEE62798DE

P433

Q38043841-08C458F8-0EB9-4F0C-8C6D-016EA9B41ACB

P478

Q38043841-352613D7-A19C-4F3D-8714-1F82AF898D14

P577

Q38043841-A2B72874-9B7D-4792-A4D7-A8D7E47197B0

P698

Q38043841-B556259C-7E74-4ED1-B395-16A94C435C0D

P921

Q38043841-4804F9E0-1309-4A75-886B-DE48AB8020ED

P932

Q38043841-220D6B57-6172-4A99-9880-DC63105A0B58

P356

J.DRUDIS.2012.09.001

P1433

Drug Discovery Today

P1476

Biomarkers of Parkinson's disease: current status and future perspectives.

@en

P2093

Chuantao Zuo

http://www.w3.org/2001/XMLSchema#string

Jake G Hoekstra

http://www.w3.org/2001/XMLSchema#string

Jian Wang

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Travis J Cook

http://www.w3.org/2001/XMLSchema#string

P2860

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

Molecular markers of early Parkinson's disease based on gene expression in blood

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

Staging of brain pathology related to sporadic Parkinson's disease

In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Ageing and Parkinson's disease: substantia nigra regional selectivity

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

P304

155-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUDIS.2012.09.001

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22982303

http://www.w3.org/2001/XMLSchema#string

P921

P932

3557745

http://www.w3.org/2001/XMLSchema#string